Skip to main content
. 2020 Oct 9;10:574861. doi: 10.3389/fonc.2020.574861

Figure 1.

Figure 1

The in vitro cytotoxicity of different compounds in ABCB1-overexpressing cells and their corresponding parental cell. (A) The structure of sapitinib. (B) Cell availability of different treatment on SW620 and SW620/Ad300 cells. (C) Cell availability of different treatment on HEK293/pcDNA3.1 and HEK293/ABCB1 cells. *p < 0.05 versus no inhibitor group.